Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-017564

Chief Development Officer sold 3,009 shares at $6.87 ($20,672)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kaiser Peter · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-02-24 Sale : show line 1 in the form 10b5-1 −3,009 $6.87 $20,672 210,078 D
Open-market sales · 3,009 sh · avg $6.87 · $20,672
Loading xslF345X05/tm257640-2_4seq1.xml…